MedPath

Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting

Not Applicable
Recruiting
Conditions
Traumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts
Registration Number
NCT06488612
Lead Sponsor
Sohag University
Brief Summary

Split-thickness skin grafting (STSG) is one of the most commonly performed procedures to achieve wound closure. Most studies are concerned on improving the appearance of scars and shortening the healing time of the recipient sites. However, the management of the donor site usually takes a second consideration.

There is a lack of consensus on the recommended method of donor site management. Donor site morbidity of STSG is usually minimal, but that may not always be the case. Morbidity may include pigmentary abnormalities, prolonged pain and itching, delayed healing, or unfavorable scarring. So, an effort must be taken to find the optimal solution for donor site healing and minimize morbidity.

Small portions of the skin graft left at the end of the procedure or the graft pieces obtained after trimming the edges are usually discarded. There have been some studies demonstrating the benefit of the minced residual skin graft on the donor site, possibly resulting in earlier epithelialization and improving the appearance

Detailed Description

The aim of this study is to compare the duration of wound healing, scar quality and cosmetic results of donor sites after split-thickness skin grafting with and without the use of residual graft pieces as minced skin grafts.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • All patients undergoing split-thickness skin grafting, between 12 - 60 years of age.
Exclusion Criteria
  • Patients under the age of 12 years or above 60 years.
  • Patients with a known tendency for hypertrophic scarring/keloids
  • Pregnancy
  • Co-morbid factors such as uncontrolled diabetes, ischemic heart disease, renal failure or Collagen vascular disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Scar qualityFollow up at 1 month, 3 months, 6 months

using POSAS scale.

• Patient Observer Scar Assesment Scale (POSAS) is a validated scale that measures scar quality by evaluating visual, tactile, and sensory characteristics of the scar from two different perspectives: the patient perspective and the surgeons' perspective.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Plastic surgery department, Faculty of medicine, Sohag university

🇪🇬

Sohag, Egypt

Plastic surgery department, Faculty of medicine, Sohag university
🇪🇬Sohag, Egypt
Mohamed Abd El-Mawla Mohamed, Resident plastic surgeon
Contact
+0201221953861
mohamed_abdelmageed@med.sohag.edu.eg
Gamal Yousef Elsayed, Professor of plastic surgery
Contact
+20 115 6996929

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.